Bauer Philip M, Fulton David, Boo Yong Chool, Sorescu George P, Kemp Bruce E, Jo Hanjoong, Sessa William C
Department of Pharmacology and Vascular Cell Signaling and Therapeutics Program, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Connecticut 06536, USA.
J Biol Chem. 2003 Apr 25;278(17):14841-9. doi: 10.1074/jbc.M211926200. Epub 2003 Feb 18.
We examined the influence of individual serine phosphorylation sites in endothelial nitric-oxide synthase (eNOS) on basal and stimulated NO release, cooperative phosphorylation, and co-association with hsp90 and Akt. Mutation of the serine phosphorylation sites 116, 617, and 1179 to alanines affected the phospho-state of at least one other site, demonstrating cooperation between multiple phosphorylation events, whereas mutation of serine 635 to alanine did not cause compensation. Mutation of serines 116 and 617 to alanine promoted a greater protein-protein interaction with hsp90 and Akt and greater phosphorylation on serine 1179, the major site for Akt phosphorylation. More importantly, using alanine substitutions, Ser-116 is important for agonist, but not basal NO release, Ser-635 is important for basal, but not stimulated, Ser-617 negatively regulates basal and stimulated NO release, and Ser-1179 phosphorylation is stimulatory for both basal and agonist-mediated NO release. Using putative "gain of function" mutants (serine to aspartate) serines 635 and 1179 are important positive regulators of basal and stimulated NO release. S635D eNOS is the most efficacious, yielding 5-fold increases in basal and 2-fold increases in stimulated NO release from cells. However, S617A and S617D eNOS both increased NO release with opposite actions in NOS activity assays. Thus, multiple serine phosphorylation events regulate basal and stimulate NO release with Ser-635 and Ser-1179 being important positive regulatory sites and Ser-116 as a negative regulatory. Ser-617 may not be important for directly regulating NO release but is important as a modulator of phosphorylation at other sites and protein-protein interactions.
我们研究了内皮型一氧化氮合酶(eNOS)中各个丝氨酸磷酸化位点对基础和刺激状态下一氧化氮(NO)释放、协同磷酸化以及与热休克蛋白90(hsp90)和蛋白激酶B(Akt)共缔合的影响。将丝氨酸磷酸化位点116、617和1179突变为丙氨酸会影响至少一个其他位点的磷酸化状态,这表明多个磷酸化事件之间存在协同作用,而将丝氨酸635突变为丙氨酸则不会引发补偿效应。将丝氨酸116和617突变为丙氨酸会促进与hsp90和Akt之间更强的蛋白质 - 蛋白质相互作用,并使丝氨酸1179(Akt磷酸化的主要位点)上的磷酸化增强。更重要的是,通过丙氨酸替代实验发现,丝氨酸116对激动剂诱导的而非基础状态下的NO释放很重要,丝氨酸635对基础状态下的而非刺激状态下的NO释放很重要,丝氨酸617对基础和刺激状态下的NO释放均起负调节作用,而丝氨酸1179的磷酸化对基础和激动剂介导的NO释放均有刺激作用。使用假定的“功能获得”突变体(丝氨酸突变为天冬氨酸)时,丝氨酸635和1179是基础和刺激状态下NO释放的重要正调节因子。S635D - eNOS最为有效,可使细胞基础状态下的NO释放增加5倍,刺激状态下增加2倍。然而,在一氧化氮合酶活性测定中,S617A - eNOS和S617D - eNOS均增加了NO释放,但作用相反。因此,多个丝氨酸磷酸化事件调节基础和刺激状态下的NO释放,其中丝氨酸635和丝氨酸1179是重要的正调节位点,丝氨酸116是负调节位点。丝氨酸617可能对直接调节NO释放并不重要,但作为其他位点磷酸化和蛋白质 - 蛋白质相互作用的调节剂很重要。